Biospecifics Technologies (BSTC) Tops Q2 EPS by 2c

August 9, 2016 5:10 PM EDT

Biospecifics Technologies (NASDAQ: BSTC) reported Q2 EPS of $0.37, $0.02 better than the analyst estimate of $0.35. Revenue for the quarter came in at $6.2 million versus the consensus estimate of $6.25 million.

For earnings history and earnings-related data on Biospecifics Technologies (BSTC) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings